Novel N-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson’s Disease

Novel N-Linked Isoquinoline Amides as LRRK2 Inhibitors for Treating Parkinson’s Disease
ACS Med Chem Lett. 2022 Jun 21;13(7):1008-1009. doi: 10.1021/acsmedchemlett.2c00263. eCollection 2022 Jul 14.NO ABSTRACTPMID:35928851 | PMC:PMC9345376 | DOI:10.1021/acsmedchemlett.2c00263 ... read more
Source: PubMedPublished on 2022-08-05By Ram W Sabnis